OTCMKTS:CTTC Calmare Therapeutics (CTTC) Stock Forecast, Price & News Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest About Calmare Therapeutics (OTCMKTS:CTTC) StockCalmare Therapeutics, Inc. engages in the research, development, and commercialization of chronic, neuropathic pain and wound affliction devices. It offers licensing and technology sourcing. The company was founded in 1968 and is headquartered in Fairfield, CT.Read More Receive CTTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Calmare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CTTC Stock News HeadlinesMay 18, 2023 | americanbankingnews.comHead to Head Survey: STRATA Skin Sciences (NASDAQ:SSKN) and Calmare Therapeutics (OTCMKTS:CTTC)May 6, 2023 | morningstar.comUnited Therapeutics Corp UTHR Stock QuoteMay 27, 2023 | Behind the Markets (Ad)[BREAKING] Small Firm Develops World's First Anti-Aircraft LaserSmall cap wins $1.65 billion contract to make them. GlobeNewswire says this is a $51.1 Billion market by 2026. See why this stock could soar 2,476% >>>February 27, 2023 | benzinga.comBeam Therapeutics Stock (NASDAQ:BEAM), Quotes and News SummaryJanuary 14, 2022 | nasdaq.comCalmare Therapeutics Inc (CTTC)August 18, 2021 | barrons.comCalmare Therapeutics Inc.December 24, 2020 | markets.businessinsider.comNews for Calmare Therapeutics IncNovember 15, 2020 | bloomberg.comCalmare Therapeutics IncMay 27, 2023 | Behind the Markets (Ad)"Chilling War Games Show US Forces Crushed" – FOX NEWS=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>October 24, 2020 | finance.yahoo.comCalmare Therapeutics Incorporated (CTTC)August 3, 2020 | finanznachrichten.deCalmare Therapeutics Incorporated: Insurance Carrier Denial of Coverage for Calmare Pain Mitigation Therapy Overturned in CaliforniaAugust 3, 2020 | finance.yahoo.comInsurance Carrier Denial of Coverage for Calmare Pain Mitigation Therapy(TM) Overturned in CaliforniaJune 9, 2020 | finance.yahoo.comCalmare Therapeutics Awarded $2.5 Million, Five-Year Contract by U.S. Department of Veteran Affairs for Calmare(R) Pain Therapy DevicesMarch 16, 2020 | www.finanznachrichten.deCalmare Therapeutics Incorporated: Calmare Therapeutics CEO Issues StatementMarch 16, 2020 | finance.yahoo.comCalmare Therapeutics CEO Issues StatementNovember 6, 2019 | finance.yahoo.comCalmare Therapeutics Has $842,000 Judgment Vacated by the U.S. Court Of Appeals for the Second CircuitJune 3, 2019 | www.finanznachrichten.deCalmare Therapeutics Incorporated: Calmare Therapeutics Receives Favorable Decision From The U.S. Court Of Appeals For The Second CircuitJune 3, 2019 | finance.yahoo.comCalmare Therapeutics Receives Favorable Decision From The U.S. Court Of Appeals For The Second CircuitMarch 26, 2019 | www.finanznachrichten.deCalmare Therapeutics Incorporated: Calmare Therapeutics Receives Two Favorable Rulings In Delaware Chancery CourtMarch 25, 2019 | finance.yahoo.comCalmare Therapeutics Receives Two Favorable Rulings In Delaware Chancery CourtMarch 19, 2019 | www.finanznachrichten.deCalmare Therapeutics Incorporated: Calmare Therapeutics Has $10.4 Million Judgment Vacated by The U.S. Court of Appeals for The Second CircuitMarch 19, 2019 | finance.yahoo.comCalmare Therapeutics Has $10.4 Million Judgment Vacated by The U.S. Court of Appeals for The Second CircuitSee More Headlines Receive CTTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Calmare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CTTC Company Calendar Today5/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CTTC CUSIPN/A CIK102198 Webwww.calmaretherapeutics.com Phone(203) 368-6044Fax203-368-5399Employees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.27 Key ExecutivesConrad F. MirPresident, Chief Executive Officer & DirectorThomas P. RichtarichChief Financial OfficerStephen J. D'AmatoChief Medical OfficerDonna J. MaysManager-Administrative ServicesWilliam LipfordHead-Product SalesKey CompetitorsAdynxxOTCMKTS:ADYXCVR MedicalOTCMKTS:CRRVFDex LiquidatingOTCMKTS:DXTRQEndologixOTCMKTS:ELGXQLifePointOTCMKTS:LFPIView All Competitors CTTC Stock - Frequently Asked Questions What other stocks do shareholders of Calmare Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Calmare Therapeutics investors own include Idera Pharmaceuticals (IDRA), Brainstorm Cell Therapeutics (BCLI), Costco Wholesale (COST), Blue Apron (APRN), Arista Networks (ANET), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER) and Enact (ACT). What is Calmare Therapeutics' stock symbol? Calmare Therapeutics trades on the OTCMKTS under the ticker symbol "CTTC." How do I buy shares of Calmare Therapeutics? Shares of CTTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. How can I contact Calmare Therapeutics? Calmare Therapeutics' mailing address is 1375 KINGS HIGHWAY EAST SUITE 400, FAIRFIELD CT, 06824. The official website for the company is www.calmaretherapeutics.com. The company can be reached via phone at (203) 368-6044, via email at ctt@calmaretherapeutics.com, or via fax at 203-368-5399. This page (OTCMKTS:CTTC) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calmare Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.